Multimodal cell atlas of the ageing human skeletal muscle
Muscle atrophy and functional decline (sarcopenia) are common manifestations of frailty and are critical contributors to morbidity and mortality in older people1. Deciphering the molecular mechanisms underlying sarcopenia has major implications for understanding human ageing2. Yet, progress has been slow, partly due to the difficulties of characterizing skeletal muscle niche heterogeneity (whereby myofibres are the most abundant) and obtaining well-characterized human samples3,4. Here we generate a single-cell/single-nucleus transcriptomic and chromatin accessibility map of human limb skeletal muscles encompassing over 387,000 cells/nuclei from individuals aged 15 to 99 years with distinct fitness and frailty levels. We describe how cell populations change during ageing, including the emergence of new populations in older people, and the cell-specific and multicellular network features (at the transcriptomic and epigenetic levels) associated with these changes. On the basis of cross-comparison with genetic data, we also identify key elements of chromatin architecture that mark susceptibility to sarcopenia. Our study provides a basis for identifying targets in the skeletal muscle that are amenable to medical, pharmacological and lifestyle interventions in late life.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Aging
3 publications, 3.06%
|
|
|
Advanced Science
3 publications, 3.06%
|
|
|
Aging Cell
3 publications, 3.06%
|
|
|
Nature Aging
3 publications, 3.06%
|
|
|
International Journal of Molecular Sciences
3 publications, 3.06%
|
|
|
bioRxiv
2 publications, 2.04%
|
|
|
Mechanisms of Ageing and Development
2 publications, 2.04%
|
|
|
iScience
2 publications, 2.04%
|
|
|
Nature Communications
2 publications, 2.04%
|
|
|
Journal of Cachexia, Sarcopenia and Muscle
2 publications, 2.04%
|
|
|
Scientific Reports
2 publications, 2.04%
|
|
|
Frontiers in Physiology
2 publications, 2.04%
|
|
|
Biology
1 publication, 1.02%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 1.02%
|
|
|
Communications Biology
1 publication, 1.02%
|
|
|
Frontiers in Veterinary Science
1 publication, 1.02%
|
|
|
Free Radical Biology and Medicine
1 publication, 1.02%
|
|
|
Nutrients
1 publication, 1.02%
|
|
|
Ageing Research Reviews
1 publication, 1.02%
|
|
|
NAR Molecular Medicine
1 publication, 1.02%
|
|
|
Nature Cell Biology
1 publication, 1.02%
|
|
|
FASEB Journal
1 publication, 1.02%
|
|
|
International Journal of Biological Macromolecules
1 publication, 1.02%
|
|
|
Cell Metabolism
1 publication, 1.02%
|
|
|
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
1 publication, 1.02%
|
|
|
Cells
1 publication, 1.02%
|
|
|
Nature Reviews Endocrinology
1 publication, 1.02%
|
|
|
Journal of Food Bioactives
1 publication, 1.02%
|
|
|
Genes and Development
1 publication, 1.02%
|
|
|
1
2
3
|
Publishers
|
5
10
15
20
25
|
|
|
Springer Nature
23 publications, 23.47%
|
|
|
Elsevier
19 publications, 19.39%
|
|
|
Cold Spring Harbor Laboratory
14 publications, 14.29%
|
|
|
Wiley
14 publications, 14.29%
|
|
|
MDPI
8 publications, 8.16%
|
|
|
Frontiers Media S.A.
8 publications, 8.16%
|
|
|
Oxford University Press
2 publications, 2.04%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
2 publications, 2.04%
|
|
|
International Society for Nutraceuticals & Functional Foods (ISNFF)
1 publication, 1.02%
|
|
|
Public Library of Science (PLoS)
1 publication, 1.02%
|
|
|
American Society for Microbiology
1 publication, 1.02%
|
|
|
Annual Reviews
1 publication, 1.02%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 1.02%
|
|
|
Baishideng Publishing Group
1 publication, 1.02%
|
|
|
Hindawi Limited
1 publication, 1.02%
|
|
|
Taylor & Francis
1 publication, 1.02%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.